Paper70467
Persistence of antigen-binding cells with surface tolerogen: isologous versus heterologous immunoglobulin carriers.
Venkataraman M and 3 others. J Immunol, 1977. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Persistence of antigen-binding cells with surface tolerogen: isologous versus heterologous immunoglobulin carriers. Papers, record 70467. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/70467
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Persistence of antigen-binding cells with surface tolerogen: isologous versus heterologous immunoglobulin carriers.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Binding Sites, Antibody | Major topic |
| Carrier Proteins | Major topic |
| Immune Tolerance | Major topic |
| Immunity, Cellular | Major topic |
| Immunoglobulin G | Major topic |
| Animals | |
| Fluorescent Antibody Technique | |
| Hemocyanins | |
| Lymphocytes | |
| Male | |
| Mice | |
| Mice, Inbred C3H | |
| Mice, Inbred C57BL | |
| Mice, Inbred DBA | |
| Sheep | |
| Time Factors | |
| gamma-Globulins |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24762281 | Inhibitors - cellular aspects and novel approaches for tolerance. | Haemophilia | 2014 | https://conductscience.org/library/papers/24762281 | PubMed |
| 20485267 | B-cell-delivered gene therapy induces functional T regulatory cells and leads to a loss of antigen-specific effector cells. | Mol Ther | 2010 | https://conductscience.org/library/papers/20485267 | PubMed |
| 18606668 | B cells induce tolerance by presenting endogenous peptide-IgG on MHC class II molecules via an IFN-gamma-inducible lysosomal thiol reductase-dependent pathway. | J Immunol | 2008 | https://conductscience.org/library/papers/18606668 | PubMed |
| 8643522 | Epitope-specific tolerance induction with an engineered immunoglobulin. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8643522 | PubMed |
| 357291 | Comparative immunological analysis of host plasma proteins bound to bloodstream forms of Trypanosoma brucei subspecies. | Infect Immun | 1978 | https://conductscience.org/library/papers/357291 | PubMed |
| 93080 | B-cell subsets responsive to fluorescein-conjugated antigens. III. Differential effect of E. Coli lipopolysaccharide on T-dependent and T-independent responses in vivo. | Immunology | 1979 | https://conductscience.org/library/papers/93080 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/70467
GET https://conductscience.org/api/papers/v1/70467/authors